nodes	percent_of_prediction	percent_of_DWPC	metapath
Sirolimus—MTOR—leg—abdominal aortic aneurysm	0.0736	0.16	CbGeAlD
Sirolimus—MTOR—hindlimb—abdominal aortic aneurysm	0.0658	0.142	CbGeAlD
Sirolimus—EIF4E—connective tissue—abdominal aortic aneurysm	0.0416	0.0902	CbGeAlD
Sirolimus—EIF4E—kidney—abdominal aortic aneurysm	0.0354	0.0768	CbGeAlD
Sirolimus—EIF4E—Transport of the SLBP independent Mature mRNA—AAAS—abdominal aortic aneurysm	0.031	0.0576	CbGpPWpGaD
Sirolimus—EIF4E—Transport of the SLBP Dependant Mature mRNA—AAAS—abdominal aortic aneurysm	0.0303	0.0562	CbGpPWpGaD
Sirolimus—MTOR—blood plasma—abdominal aortic aneurysm	0.0302	0.0655	CbGeAlD
Sirolimus—EIF4E—Transport of Mature mRNA Derived from an Intronless Transcript—AAAS—abdominal aortic aneurysm	0.0289	0.0536	CbGpPWpGaD
Sirolimus—EIF4E—Transport of Mature mRNAs Derived from Intronless Transcripts—AAAS—abdominal aortic aneurysm	0.0282	0.0524	CbGpPWpGaD
Sirolimus—FKBP1A—blood plasma—abdominal aortic aneurysm	0.0272	0.0589	CbGeAlD
Sirolimus—SLCO1B1—blood plasma—abdominal aortic aneurysm	0.0231	0.05	CbGeAlD
Sirolimus—EIF4E—Transport of Mature mRNA derived from an Intron-Containing Transcript—AAAS—abdominal aortic aneurysm	0.0217	0.0403	CbGpPWpGaD
Sirolimus—EIF4E—Transport of Mature Transcript to Cytoplasm—AAAS—abdominal aortic aneurysm	0.0204	0.0379	CbGpPWpGaD
Sirolimus—MTOR—SREBF and miR33 in cholesterol and lipid homeostasis—LDLR—abdominal aortic aneurysm	0.0195	0.0361	CbGpPWpGaD
Sirolimus—FGF2—spinal cord—abdominal aortic aneurysm	0.0168	0.0365	CbGeAlD
Sirolimus—EIF4E—Antiviral mechanism by IFN-stimulated genes—AAAS—abdominal aortic aneurysm	0.0166	0.0308	CbGpPWpGaD
Sirolimus—MTOR—connective tissue—abdominal aortic aneurysm	0.0161	0.0349	CbGeAlD
Sirolimus—FKBP1A—connective tissue—abdominal aortic aneurysm	0.0145	0.0314	CbGeAlD
Sirolimus—MTOR—kidney—abdominal aortic aneurysm	0.0137	0.0297	CbGeAlD
Sirolimus—FKBP1A—kidney—abdominal aortic aneurysm	0.0123	0.0267	CbGeAlD
Sirolimus—EIF4E—Signaling mediated by p38-alpha and p38-beta—NOS2—abdominal aortic aneurysm	0.0122	0.0226	CbGpPWpGaD
Sirolimus—CYP3A5—blood plasma—abdominal aortic aneurysm	0.0118	0.0257	CbGeAlD
Sirolimus—MTOR—spinal cord—abdominal aortic aneurysm	0.0107	0.0231	CbGeAlD
Sirolimus—SLC47A1—kidney—abdominal aortic aneurysm	0.0106	0.023	CbGeAlD
Sirolimus—SLCO1B1—kidney—abdominal aortic aneurysm	0.0105	0.0227	CbGeAlD
Sirolimus—FKBP1A—spinal cord—abdominal aortic aneurysm	0.0096	0.0208	CbGeAlD
Sirolimus—EIF4E—Processing of Capped Intron-Containing Pre-mRNA—AAAS—abdominal aortic aneurysm	0.00931	0.0173	CbGpPWpGaD
Sirolimus—EIF4E—Signaling mediated by p38-alpha and p38-beta—PTGS2—abdominal aortic aneurysm	0.00895	0.0166	CbGpPWpGaD
Sirolimus—CYP3A4—blood plasma—abdominal aortic aneurysm	0.00889	0.0193	CbGeAlD
Sirolimus—SLC47A1—spinal cord—abdominal aortic aneurysm	0.00825	0.0179	CbGeAlD
Sirolimus—EIF4E—Interferon Signaling—AAAS—abdominal aortic aneurysm	0.00819	0.0152	CbGpPWpGaD
Sirolimus—FGF2—Angiopoietin receptor Tie2-mediated signaling—AGTR1—abdominal aortic aneurysm	0.00791	0.0147	CbGpPWpGaD
Sirolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—PTGS2—abdominal aortic aneurysm	0.00763	0.0142	CbGpPWpGaD
Sirolimus—EIF4E—BDNF signaling pathway—NCF1—abdominal aortic aneurysm	0.00761	0.0141	CbGpPWpGaD
Sirolimus—MTOR—Oncostatin M Signaling Pathway—LDLR—abdominal aortic aneurysm	0.00634	0.0118	CbGpPWpGaD
Sirolimus—ABCB1—blood plasma—abdominal aortic aneurysm	0.00629	0.0136	CbGeAlD
Sirolimus—EIF4E—Structural Pathway of Interleukin 1 (IL-1)—NFKB1—abdominal aortic aneurysm	0.00613	0.0114	CbGpPWpGaD
Sirolimus—MTOR—SREBP signalling—LDLR—abdominal aortic aneurysm	0.00604	0.0112	CbGpPWpGaD
Sirolimus—FGF2—Angiogenesis—MMP9—abdominal aortic aneurysm	0.0059	0.011	CbGpPWpGaD
Sirolimus—SLC47A1—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	0.00576	0.0107	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of RNA—AAAS—abdominal aortic aneurysm	0.0057	0.0106	CbGpPWpGaD
Sirolimus—EIF4E—Cytokine Signaling in Immune system—AAAS—abdominal aortic aneurysm	0.00547	0.0102	CbGpPWpGaD
Sirolimus—CYP3A5—kidney—abdominal aortic aneurysm	0.00537	0.0116	CbGeAlD
Sirolimus—FKBP1A—TGF-beta Receptor Signaling—SERPINE1—abdominal aortic aneurysm	0.00531	0.00986	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—ELN—abdominal aortic aneurysm	0.00517	0.00961	CbGpPWpGaD
Sirolimus—MTOR—Senescence and Autophagy in Cancer—MMP14—abdominal aortic aneurysm	0.00491	0.00911	CbGpPWpGaD
Sirolimus—FGF2—Syndecan-4-mediated signaling events—MMP9—abdominal aortic aneurysm	0.00469	0.0087	CbGpPWpGaD
Sirolimus—FGF2—Angiopoietin receptor Tie2-mediated signaling—MMP2—abdominal aortic aneurysm	0.00436	0.0081	CbGpPWpGaD
Sirolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—SERPINE1—abdominal aortic aneurysm	0.00432	0.00802	CbGpPWpGaD
Sirolimus—MTOR—Oncostatin M Signaling Pathway—MMP3—abdominal aortic aneurysm	0.00424	0.00788	CbGpPWpGaD
Sirolimus—EIF4E—Leptin signaling pathway—NFKB1—abdominal aortic aneurysm	0.00422	0.00784	CbGpPWpGaD
Sirolimus—EIF4E—Validated targets of C-MYC transcriptional activation—MMP9—abdominal aortic aneurysm	0.00409	0.0076	CbGpPWpGaD
Sirolimus—CYP3A4—kidney—abdominal aortic aneurysm	0.00403	0.00873	CbGeAlD
Sirolimus—FKBP1A—TGF-beta Receptor Signaling—NFKB1—abdominal aortic aneurysm	0.00403	0.00748	CbGpPWpGaD
Sirolimus—MTOR—VEGFA-VEGFR2 Pathway—NCF1—abdominal aortic aneurysm	0.00398	0.00739	CbGpPWpGaD
Sirolimus—MTOR—Signaling by VEGF—NCF1—abdominal aortic aneurysm	0.00376	0.00698	CbGpPWpGaD
Sirolimus—FGF2—MicroRNAs in cardiomyocyte hypertrophy—AGT—abdominal aortic aneurysm	0.00368	0.00683	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—LOX—abdominal aortic aneurysm	0.00359	0.00666	CbGpPWpGaD
Sirolimus—FKBP1A—Spinal Cord Injury—NOS2—abdominal aortic aneurysm	0.00338	0.00627	CbGpPWpGaD
Sirolimus—MTOR—IL12-mediated signaling events—NOS2—abdominal aortic aneurysm	0.00326	0.00606	CbGpPWpGaD
Sirolimus—FGF2—Angiopoietin receptor Tie2-mediated signaling—NFKB1—abdominal aortic aneurysm	0.00324	0.00603	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—MMP14—abdominal aortic aneurysm	0.00316	0.00587	CbGpPWpGaD
Sirolimus—MTOR—BDNF signaling pathway—NCF1—abdominal aortic aneurysm	0.00314	0.00583	CbGpPWpGaD
Sirolimus—MTOR—IL2 signaling events mediated by PI3K—NFKB1—abdominal aortic aneurysm	0.00306	0.00569	CbGpPWpGaD
Sirolimus—FKBP1A—Spinal Cord Injury—CCL2—abdominal aortic aneurysm	0.00304	0.00565	CbGpPWpGaD
Sirolimus—FGF2—Cardiac Hypertrophic Response—NFKB1—abdominal aortic aneurysm	0.00301	0.00558	CbGpPWpGaD
Sirolimus—SLC47A1—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.00293	0.00543	CbGpPWpGaD
Sirolimus—ABCB1—kidney—abdominal aortic aneurysm	0.00285	0.00618	CbGeAlD
Sirolimus—MTOR—Oncostatin M Signaling Pathway—CCL2—abdominal aortic aneurysm	0.00276	0.00512	CbGpPWpGaD
Sirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—AGT—abdominal aortic aneurysm	0.00273	0.00507	CbGpPWpGaD
Sirolimus—FGF2—Endochondral Ossification—MMP9—abdominal aortic aneurysm	0.00269	0.005	CbGpPWpGaD
Sirolimus—MTOR—Oncostatin M Signaling Pathway—SERPINE1—abdominal aortic aneurysm	0.00258	0.00478	CbGpPWpGaD
Sirolimus—MTOR—TSLP Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.00253	0.0047	CbGpPWpGaD
Sirolimus—EIF4E—BDNF signaling pathway—NFKB1—abdominal aortic aneurysm	0.0025	0.00465	CbGpPWpGaD
Sirolimus—FKBP1A—Spinal Cord Injury—PTGS2—abdominal aortic aneurysm	0.00248	0.00461	CbGpPWpGaD
Sirolimus—MTOR—RANKL/RANK Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.00223	0.00414	CbGpPWpGaD
Sirolimus—MTOR—Cardiac Hypertrophic Response—NFKB1—abdominal aortic aneurysm	0.00223	0.00414	CbGpPWpGaD
Sirolimus—ABCB1—spinal cord—abdominal aortic aneurysm	0.00222	0.00481	CbGeAlD
Sirolimus—FKBP1A—Spinal Cord Injury—MMP9—abdominal aortic aneurysm	0.00218	0.00404	CbGpPWpGaD
Sirolimus—FGF2—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—abdominal aortic aneurysm	0.00214	0.00398	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—SELL—abdominal aortic aneurysm	0.00214	0.00397	CbGpPWpGaD
Sirolimus—MTOR—IL12-mediated signaling events—NFKB1—abdominal aortic aneurysm	0.00208	0.00386	CbGpPWpGaD
Sirolimus—SLCO1B1—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	0.00206	0.00382	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—SELL—abdominal aortic aneurysm	0.00196	0.00364	CbGpPWpGaD
Sirolimus—MTOR—Oncostatin M Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.00195	0.00363	CbGpPWpGaD
Sirolimus—MTOR—Regulation of Telomerase—NFKB1—abdominal aortic aneurysm	0.00188	0.0035	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—MMP3—abdominal aortic aneurysm	0.00186	0.00346	CbGpPWpGaD
Sirolimus—FGF2—Neural Crest Differentiation—NFKB1—abdominal aortic aneurysm	0.00185	0.00343	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—AAAS—abdominal aortic aneurysm	0.00179	0.00332	CbGpPWpGaD
Sirolimus—EIF4E—Gene Expression—AAAS—abdominal aortic aneurysm	0.00178	0.0033	CbGpPWpGaD
Sirolimus—MTOR—Senescence and Autophagy in Cancer—SERPINE1—abdominal aortic aneurysm	0.00175	0.00326	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—AGTR1—abdominal aortic aneurysm	0.00175	0.00326	CbGpPWpGaD
Sirolimus—MTOR—Leptin signaling pathway—NFKB1—abdominal aortic aneurysm	0.00174	0.00323	CbGpPWpGaD
Sirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.00169	0.00314	CbGpPWpGaD
Sirolimus—MTOR—Senescence and Autophagy in Cancer—CDKN2A—abdominal aortic aneurysm	0.00164	0.00304	CbGpPWpGaD
Sirolimus—MTOR—CXCR4-mediated signaling events—MMP9—abdominal aortic aneurysm	0.00161	0.00298	CbGpPWpGaD
Sirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—abdominal aortic aneurysm	0.00159	0.00295	CbGpPWpGaD
Sirolimus—EIF4E—Cytokine Signaling in Immune system—NFKB1—abdominal aortic aneurysm	0.00147	0.00273	CbGpPWpGaD
Sirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.00147	0.00272	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—NCF1—abdominal aortic aneurysm	0.00146	0.00271	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—SELL—abdominal aortic aneurysm	0.00145	0.0027	CbGpPWpGaD
Sirolimus—FGF2—Signaling by SCF-KIT—MMP9—abdominal aortic aneurysm	0.00143	0.00266	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—LRP1—abdominal aortic aneurysm	0.00139	0.00259	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—NCF1—abdominal aortic aneurysm	0.00134	0.00248	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00133	0.00247	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—SOD2—abdominal aortic aneurysm	0.0013	0.00242	CbGpPWpGaD
Sirolimus—ABCB1—HIF-1-alpha transcription factor network—NOS2—abdominal aortic aneurysm	0.0013	0.00242	CbGpPWpGaD
Sirolimus—FGF2—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.00128	0.00238	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00124	0.00231	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—AGT—abdominal aortic aneurysm	0.00124	0.0023	CbGpPWpGaD
Sirolimus—FGF2—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—abdominal aortic aneurysm	0.00124	0.0023	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—AAAS—abdominal aortic aneurysm	0.00121	0.00225	CbGpPWpGaD
Sirolimus—FGF2—Immune System—SELL—abdominal aortic aneurysm	0.00119	0.00221	CbGpPWpGaD
Sirolimus—FGF2—Fc epsilon receptor (FCERI) signaling—NFKB1—abdominal aortic aneurysm	0.00118	0.00219	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—MMP2—abdominal aortic aneurysm	0.00115	0.00214	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—SERPINE1—abdominal aortic aneurysm	0.00113	0.0021	CbGpPWpGaD
Sirolimus—FGF2—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.00111	0.00206	CbGpPWpGaD
Sirolimus—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—abdominal aortic aneurysm	0.0011	0.00203	CbGpPWpGaD
Sirolimus—FGF2—B Cell Activation—NFKB1—abdominal aortic aneurysm	0.00109	0.00203	CbGpPWpGaD
Sirolimus—MTOR—Signaling by SCF-KIT—MMP9—abdominal aortic aneurysm	0.00106	0.00197	CbGpPWpGaD
Sirolimus—FGF2—Disease—LRP1—abdominal aortic aneurysm	0.00106	0.00196	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—LDLR—abdominal aortic aneurysm	0.00106	0.00196	CbGpPWpGaD
Sirolimus—SLCO1B1—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.00105	0.00194	CbGpPWpGaD
Sirolimus—MTOR—BDNF signaling pathway—NFKB1—abdominal aortic aneurysm	0.00103	0.00192	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—CCL2—abdominal aortic aneurysm	0.00102	0.00189	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00101	0.00187	CbGpPWpGaD
Sirolimus—MTOR—Integrated Breast Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000995	0.00185	CbGpPWpGaD
Sirolimus—FGF2—Immune System—AAAS—abdominal aortic aneurysm	0.000993	0.00184	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—NCF1—abdominal aortic aneurysm	0.000992	0.00184	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—NCF1—abdominal aortic aneurysm	0.000988	0.00184	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000976	0.00181	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—MMP2—abdominal aortic aneurysm	0.000969	0.0018	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000961	0.00178	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000943	0.00175	CbGpPWpGaD
Sirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—abdominal aortic aneurysm	0.000918	0.0017	CbGpPWpGaD
Sirolimus—FGF2—Disease—AAAS—abdominal aortic aneurysm	0.000917	0.0017	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000913	0.0017	CbGpPWpGaD
Sirolimus—MTOR—Immune System—SELL—abdominal aortic aneurysm	0.000882	0.00164	CbGpPWpGaD
Sirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—NFKB1—abdominal aortic aneurysm	0.000876	0.00163	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—MMP9—abdominal aortic aneurysm	0.000866	0.00161	CbGpPWpGaD
Sirolimus—FGF2—Immune System—NCF1—abdominal aortic aneurysm	0.000811	0.00151	CbGpPWpGaD
Sirolimus—MTOR—B Cell Activation—NFKB1—abdominal aortic aneurysm	0.000811	0.00151	CbGpPWpGaD
Sirolimus—FGF2—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.000804	0.00149	CbGpPWpGaD
Sirolimus—FGF2—Disease—LDLR—abdominal aortic aneurysm	0.000801	0.00149	CbGpPWpGaD
Sirolimus—MTOR—Disease—LRP1—abdominal aortic aneurysm	0.000784	0.00146	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—CDKN2A—abdominal aortic aneurysm	0.000784	0.00146	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000758	0.00141	CbGpPWpGaD
Sirolimus—FGF2—Disease—NCF1—abdominal aortic aneurysm	0.000749	0.00139	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00074	0.00137	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00074	0.00137	CbGpPWpGaD
Sirolimus—MTOR—Immune System—AAAS—abdominal aortic aneurysm	0.000737	0.00137	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—MMP2—abdominal aortic aneurysm	0.000698	0.0013	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000692	0.00129	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000692	0.00129	CbGpPWpGaD
Sirolimus—MTOR—Disease—AAAS—abdominal aortic aneurysm	0.000681	0.00126	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000675	0.00125	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—NFKB1—abdominal aortic aneurysm	0.000636	0.00118	CbGpPWpGaD
Sirolimus—EIF4E—Gene Expression—SERPINE1—abdominal aortic aneurysm	0.00063	0.00117	CbGpPWpGaD
Sirolimus—MTOR—Immune System—NCF1—abdominal aortic aneurysm	0.000602	0.00112	CbGpPWpGaD
Sirolimus—MTOR—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.000597	0.00111	CbGpPWpGaD
Sirolimus—MTOR—Disease—LDLR—abdominal aortic aneurysm	0.000594	0.0011	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000561	0.00104	CbGpPWpGaD
Sirolimus—MTOR—Disease—NCF1—abdominal aortic aneurysm	0.000556	0.00103	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000556	0.00103	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000549	0.00102	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—APOE—abdominal aortic aneurysm	0.000547	0.00102	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000533	0.00099	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—MMP9—abdominal aortic aneurysm	0.000525	0.000975	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000524	0.000974	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.000524	0.000973	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000522	0.00097	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.000519	0.000964	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000514	0.000954	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—NOS2—abdominal aortic aneurysm	0.00051	0.000947	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000508	0.000943	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000498	0.000924	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000495	0.00092	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—AAAS—abdominal aortic aneurysm	0.00049	0.00091	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—NFKB1—abdominal aortic aneurysm	0.00048	0.000892	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000459	0.000852	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—AAAS—abdominal aortic aneurysm	0.00045	0.000836	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.00044	0.000818	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000439	0.000815	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—SERPINE1—abdominal aortic aneurysm	0.000429	0.000797	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—LDLR—abdominal aortic aneurysm	0.000428	0.000795	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000421	0.000782	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000416	0.000773	CbGpPWpGaD
Sirolimus—FGF2—Disease—APOE—abdominal aortic aneurysm	0.000415	0.00077	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.00041	0.000761	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.000409	0.000759	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—LDLR—abdominal aortic aneurysm	0.000393	0.000729	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000391	0.000726	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000389	0.000723	CbGpPWpGaD
Sirolimus—FGF2—Disease—NOS2—abdominal aortic aneurysm	0.000386	0.000718	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000383	0.000712	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000375	0.000697	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—PTGS2—abdominal aortic aneurysm	0.000375	0.000696	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000355	0.000659	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000341	0.000633	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.00034	0.000632	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000327	0.000607	CbGpPWpGaD
Sirolimus—FGF2—Disease—SERPINE1—abdominal aortic aneurysm	0.000325	0.000604	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—AAAS—abdominal aortic aneurysm	0.000325	0.000604	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000322	0.000598	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000314	0.000583	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000313	0.00058	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000311	0.000577	CbGpPWpGaD
Sirolimus—MTOR—Disease—APOE—abdominal aortic aneurysm	0.000308	0.000571	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000301	0.000558	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000296	0.00055	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—APOE—abdominal aortic aneurysm	0.00029	0.000539	CbGpPWpGaD
Sirolimus—MTOR—Disease—NOS2—abdominal aortic aneurysm	0.000287	0.000533	CbGpPWpGaD
Sirolimus—FGF2—Disease—PTGS2—abdominal aortic aneurysm	0.000284	0.000528	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—LDLR—abdominal aortic aneurysm	0.000284	0.000527	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000279	0.000517	CbGpPWpGaD
Sirolimus—FGF2—Immune System—NFKB1—abdominal aortic aneurysm	0.000267	0.000496	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—AAAS—abdominal aortic aneurysm	0.000245	0.000456	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000244	0.000453	CbGpPWpGaD
Sirolimus—MTOR—Disease—SERPINE1—abdominal aortic aneurysm	0.000241	0.000448	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.00023	0.000428	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000228	0.000423	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000228	0.000423	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—AGT—abdominal aortic aneurysm	0.000226	0.00042	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—APOE—abdominal aortic aneurysm	0.000222	0.000412	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—AGT—abdominal aortic aneurysm	0.00022	0.000408	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000215	0.0004	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—LDLR—abdominal aortic aneurysm	0.000214	0.000398	CbGpPWpGaD
Sirolimus—MTOR—Disease—PTGS2—abdominal aortic aneurysm	0.000211	0.000392	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—AGT—abdominal aortic aneurysm	0.000208	0.000386	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—APOE—abdominal aortic aneurysm	0.000203	0.000378	CbGpPWpGaD
Sirolimus—MTOR—Immune System—NFKB1—abdominal aortic aneurysm	0.000198	0.000368	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000181	0.000336	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000175	0.000324	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000173	0.000321	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000169	0.000314	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PTGS2—abdominal aortic aneurysm	0.000152	0.000282	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—AAAS—abdominal aortic aneurysm	0.000151	0.000281	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—AGT—abdominal aortic aneurysm	0.00015	0.000279	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—APOE—abdominal aortic aneurysm	0.000147	0.000273	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PTGS2—abdominal aortic aneurysm	0.000139	0.000259	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—LDLR—abdominal aortic aneurysm	0.000132	0.000245	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.00013	0.000241	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000128	0.000238	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—AGT—abdominal aortic aneurysm	0.000113	0.00021	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—APOE—abdominal aortic aneurysm	0.000111	0.000206	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PTGS2—abdominal aortic aneurysm	0.000101	0.000187	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PTGS2—abdominal aortic aneurysm	7.6e-05	0.000141	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—AGT—abdominal aortic aneurysm	6.98e-05	0.00013	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—APOE—abdominal aortic aneurysm	6.84e-05	0.000127	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PTGS2—abdominal aortic aneurysm	4.68e-05	8.7e-05	CbGpPWpGaD
